Osiris Therapeutics, Inc.
(NASDAQ : OSIR)

( )
OSIR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.60%150.750.0%$1866.09m
NVAXNovavax, Inc. -0.23%221.0092.9%$1381.83m
OCGNOcugen, Inc. -0.25%7.980.0%$860.90m
AMGNAmgen, Inc. 0.00%227.521.3%$600.44m
ILMNIllumina, Inc. 0.28%447.113.5%$556.54m
REGNRegeneron Pharmaceuticals, Inc. 0.61%455.942.7%$534.85m
VRTXVertex Pharmaceuticals, Inc. -0.46%212.001.9%$508.48m
GILDGilead Sciences, Inc. 0.00%62.791.0%$494.89m
BNGOBioNano Genomics, Inc. -3.19%9.700.0%$393.62m
ALXNAlexion Pharmaceuticals, Inc. 0.16%153.902.0%$385.59m
BIIBBiogen, Inc. 0.61%278.961.7%$382.79m
CRSPCRISPR Therapeutics AG -1.78%125.010.6%$296.56m
EXASEXACT Sciences Corp. -2.51%128.0018.4%$240.01m
SRNESorrento Therapeutics, Inc. -1.98%9.921.3%$235.00m
VXRTVaxart, Inc. -2.67%7.300.0%$218.12m

Company Profile

Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.